Circulating miRNAs as biomarkers of kidney disease
Journal Title: Clinical Kidney Journal - Year 2017, Vol 10, Issue 1
Abstract
Interest in microRNAs (miRNAs) has dramatically increased in recent years not only because they regulate mRNA expression, and thus many physiological or pathophysiological processes, but also because they could serve as biomarkers. Next to analysis of tissue miRNA expression, measurement in body fluids such as blood or urine is attractive because miRNA in microvesicles or bound to protein is very stable. Currently it is unclear whether these circulating miRNAs are tissue and disease specific or represent more general pathologies like inflammation. In addition pre-analytical sample handling and variable analysis techniques affect the results and thus much more work needs to be done before one can draw a final conclusion about their clinical utility.
Authors and Affiliations
Alexander Hüttenhofer, Gert Mayer
Keywords
Related Articles
- EP ID EP679675
- DOI 10.1093/ckj/sfw075
- Views 51
- Downloads 0
Does size matter? Kidney transplant donor size determines kidney function among living donors
Kidney donor outcomes are gaining attention, particularly as donor eligibility criteria continue to expand. Kidney size, a useful predictor of recipient kidney function, also likely correlates with donor outcomes. Althou...
Serum osteoprotegerin and renal function in the general population: the Tromsø Study
Serum osteoprotegerin (OPG) is elevated in patients with chronic kidney disease (CKD) and increases with decreasing renal function. However, there are limited data regarding the association between OPG and renal function...
Announcements
Effect of ethnicity and socioeconomic status on vascular access provision and performance in an urban NHS hospital
The aim of this study was to examine the effect of ethnicity, socioeconomic group (SEG) and comorbidities on provision of vascular access for haemodialysis (HD).
Palliative care for patients with end-stage renal disease: approach to treatment that aims to improve quality of life and relieve suffering for patients (and families) with chronic illnesses
Providing end-of-life care to patients suffering from chronic kidney disease (CKD) and/or end-stage renal disease often presents ethical challenges to families and health care providers. However, as the conditions these...